Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
11/2002
11/13/2002CN1379818A Process for biological production of 1,3-propanediol with high titer
11/13/2002CN1379817A Composition and methods for increasing cholesterol efflux and raising HDL using ATP binding cassettte ttansporter protein ABC1
11/13/2002CN1379816A Human G-protein coupled receptor
11/13/2002CN1379812A Process for producing microorganism-origin transglutaminase
11/13/2002CN1379811A Novel yeast variants and process for producing glycoprotein containing mammalian type sugar chain
11/13/2002CN1379783A Methods for increasing plant cell proliferation by functionally inhibiting plant cyclin inhibitor gene
11/13/2002CN1379087A Arrhythmia-resistant scorpion peptide recombined colibacillus and its configuring process
11/13/2002CN1379086A Magnetotactic bacterium of iron ore and process for separating and refining it and preparing magnetic corpuscula
11/13/2002CN1379085A Sludge magnetotactic bacterium and process for separating and purifying it and preparing magnetic corpuscula
11/13/2002CN1379084A Process for deeply removing organosulfur from fossil fuel by mycobacteria
11/13/2002CN1379083A Silicate bacteria and fertilizer containing it
11/13/2002CN1379082A Solid culture method of antrodia camphorate, its cultured solid substance, and its product and application
11/13/2002CN1378775A Technique for sowing and culturing edible rare wood-decay fungus
11/12/2002US6480791 Parallel methods for genomic analysis
11/12/2002US6479642 Cortistatin: neuropeptides
11/12/2002US6479635 Receptor activator of NF-κB
11/12/2002US6479630 Human purinergic P2U receptor
11/12/2002US6479628 Methods and materials relating to IMPDH and GMP production
11/12/2002US6479291 Cytoplasmic inhibition of gene expression by viral RNA
11/12/2002US6479277 Method and apparatus for disruption of biological material
11/12/2002US6479271 Genes encoding desulfurization enzymes
11/12/2002US6479270 Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof
11/12/2002US6479267 FY7 polymerase
11/12/2002US6479266 IKK-α proteins nucleic acids and methods
11/12/2002US6479261 Methods of using interleukin-3 (IL-3) mutant polypeptides for ex-vivo expansion of hematopoietic stem cells
11/12/2002US6479257 Method of activating protein and an apparatus therefor
11/12/2002US6479254 Polypeptide for use in treatment of lymphadenopathy, autoimmune disease and graft versus host disease; antitumor agents
11/12/2002US6479243 Method for generating libraries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules
11/12/2002US6479050 Trace element-rich additive, method for preparing same, preparation in which the additive is included and use thereof
11/12/2002CA2170515C Nucleotide sequences for novel protein tyrosine phosphatases
11/12/2002CA2156486C Mucosal competitive exclusion flora
11/12/2002CA2091061C Dna fragments coding for a bacteriophage-resistant mechanism
11/12/2002CA2068083C Anti-bacterial compound
11/12/2002CA2055963C Chimeric fibroblast growth factor
11/10/2002CA2382463A1 Hepatitis c virus (hcv) ns5b rna polymerase and mutants thereof
11/07/2002WO2002088704A2 Apparatus for using optical tweezers to manipulate materials
11/07/2002WO2002088396A2 Reagents and methods for automated in situ or microarray hybridization
11/07/2002WO2002088371A2 Method for the production of an aqueous acrylamide solution with a bio-catalyst
11/07/2002WO2002088370A2 Autogene nucleic acids encoding a secretable rna polymerase
11/07/2002WO2002088367A1 Production of the lantibiotic cinnamycin with genes isolated from streptomyces cinnamoneus
11/07/2002WO2002088366A1 Von willebrand factor (vwf)-cleaving enzyme
11/07/2002WO2002088365A1 Process for producing coenzyme q¿10?
11/07/2002WO2002088364A1 ss1,3-GALACTOSE TRANSFERASE AND DNA ENCODING THE ENZYME
11/07/2002WO2002088362A2 Regulation of human prostaglandin-f synthase 1-like protein
11/07/2002WO2002088355A1 Novel guanosine triphosphate-binding protein-coupled recepotr place 6002312 and its gene and production and use of the same
11/07/2002WO2002088354A1 The nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use
11/07/2002WO2002088353A2 Method for the stable inversion of dna sequence by site-specific recombination and dna vectors and transgenic cells thereof
11/07/2002WO2002088342A1 An enzyme preparation for improved baking quality and a process for preparing the same
11/07/2002WO2002088340A2 Alkaline protease variants and detergents and cleaning agents containing said alkaline protease variants
11/07/2002WO2002088338A2 Method for replicating the hepatitis c virus
11/07/2002WO2002088327A1 Methods for viral oncoapoptosis in cancer therapy
11/07/2002WO2002088322A2 Cell adhesion and extracellular matrix proteins
11/07/2002WO2002088321A2 Concentration and purification of analytes using electric fields
11/07/2002WO2002088317A2 Fusion molecules and methods for treatment of immune diseases
11/07/2002WO2002088316A2 G-protein coupled receptors
11/07/2002WO2002088308A2 Novel strains of rhizopus oryzae and uses thereof
11/07/2002WO2002088305A2 Isolation and identification of mouse and human transcription control elements associated with cytochrome expression
11/07/2002WO2002088178A2 Antigens of group b streptococcus and corresponding dna fragments
11/07/2002WO2002074980A3 Muteins of hypoxia inducible factor alpha and methods of use thereof
11/07/2002WO2002067857A3 Modified annexin proteins and methods for preventing thrombosis
11/07/2002WO2002040649A8 Slo2 and slo4, novel potassium channel proteins from human brain
11/07/2002WO2002038733A3 A selectable genetic marker for use in pasteurellaceae species
11/07/2002WO2002038594A9 Novel therapeutic compositions for treating infection by lawsonia spp
11/07/2002WO2002030971A3 Basb205 polypeptides and polynucleotides coding therefor
11/07/2002WO2002028897A3 Human g-protein coupled receptor and uses thereof
11/07/2002WO2002028424A3 Kyberdrug as autovaccines with immune-regulating effects
11/07/2002WO2002024930A3 Artificial ubiquitous chromatin opening elements (ucoe)
11/07/2002WO2002020565A3 Collections of repeat proteins comprising repeat modules
11/07/2002WO2002016561A3 Mfq-111, a novel human gtpase like protein
11/07/2002WO2001092300A3 Chimeric gfp-aequorin as bioluminescent ca++ reporters at the single cell level
11/07/2002WO2001048187A9 A molecular switch for regulating mammalian gene expression
11/07/2002WO2001046408A9 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes
11/07/2002WO2001029240A9 Regeneration
11/07/2002WO2001027305A9 Process for producing, methods and compositions of cholesterol lowering agents from higher basidiomycetes mushrooms
11/07/2002WO2001018218A9 Expression of proteins in genetically modified fungi
11/07/2002US20020165386 C-junction-n-terminal kinase (JNK); microbiocides; treating neurodegenerative diseases
11/07/2002US20020165383 Tenebrio antifreeze proteins
11/07/2002US20020165380 A nucleic acid probe consisting a nucleic acid molecule of at least 15 nucleotides which is complementary to the antisense sequence of a unique fragment of the sequence of a nucleic acid molecule encoding a mammalian fb41 receptor
11/07/2002US20020165379 An isolated nucleic acid encoding a monomer of a calcium-activated potassium channel, and the monomer having molecular weight 40-80 kDa, unit conductance 2-6-pS, binding to antibodies generated against specific peptide sequence
11/07/2002US20020165377 ADAM polynucleotides, polypeptides, and antibodies
11/07/2002US20020165374 Secreted protein HFEAF41
11/07/2002US20020165361 Antibody for use in the diagnosis and treatment of cell proliferation disorders
11/07/2002US20020165347 Polypeptide for use in the diagnosis, prevention and treatment of arteriosclerosis and vascular restenosis
11/07/2002US20020165346 Isolated mammalian membrane protein genes; related reagents
11/07/2002US20020165344 Bacterial mutant for generating bacterial toxins for use in developing vaccine against infections
11/07/2002US20020165256 Fermentative preparation process for and crystal forms of cytostatics
11/07/2002US20020165194 Method for selective inactivation of viral replication
11/07/2002US20020165186 Compounds that affect CD83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds
11/07/2002US20020165173 T-cell factor (TCF); constructs having multiple repeats of a TCF-binding element linked to a promoter and used to express genes encoding therapeutic proteins; drug screening for anticancer agents that suppress transcription
11/07/2002US20020165154 Lipoprotein-regulating medicaments
11/07/2002US20020165143 Identification and isolation of novel DNA
11/07/2002US20020165135 Compositions and methods related to canine IgG and canine IL-13 receptors
11/07/2002US20020165131 Histidine-rich glycoprotein
11/07/2002US20020165114 Mutant EGIII cellulase, DNA encoding such EGIII compositions and methods for obtaining same
11/07/2002US20020164804 Method for more efficient electroporation
11/07/2002US20020164797 Stable in vitro culture of plant cells and phytopathogens for use in the generation of preferential compounds
11/07/2002US20020164785 Nucleotide sequences coding membrane protein for use in the detecting ligand receptors
11/07/2002US20020164775 Removal of allergens from fabric; obtain fabric, apply spores, keep fabric static, neutralize allergen
11/07/2002US20020164774 Method and compositions for treating cellulose containing fabrics using truncated cellulase enzyme compositions
11/07/2002US20020164773 Generation of extracellular, polysaccharides of basidiomycetes mushrooms; obtain fungi, propagate in nutrient broths, isolating biomass from culture by precipitation